300254.SZ · 仟源医药
China A-shares · RS rating 67 · As of 2026-10-14
| Price | 8.71 CNY |
|---|---|
| 1-day change | -2.6% |
| RS rating (overall / 1M / 3M / 12M) | 67 / 77 / 74 / 46 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 19 / 13 / 13 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +2.5% |
| Distance from 52-week high | +40.7% |
| Market cap (USD) | $357.0M |